Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-002898
Filing Date
2017-05-10
Accepted
2017-05-10 08:01:30
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050917p.htm 10-Q 651770
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8562
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7523
4 EXHIBIT 32.1 exh_321.htm EX-32.1 6313
  Complete submission text file 0001171843-17-002898.txt   2384805

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20170331.xml EX-101.INS 281986
6 XBRL SCHEMA FILE prto-20170331.xsd EX-101.SCH 30102
7 XBRL CALCULATION FILE prto-20170331_cal.xml EX-101.CAL 25187
8 XBRL DEFINITION FILE prto-20170331_def.xml EX-101.DEF 203878
9 XBRL LABEL FILE prto-20170331_lab.xml EX-101.LAB 176091
10 XBRL PRESENTATION FILE prto-20170331_pre.xml EX-101.PRE 217008
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 17828529
SIC: 2836 Biological Products, (No Diagnostic Substances)